Cooperative Agreement U48DP006837
Award Date
9/30/24
Completion Date
9/29/29
Dollars Obligated
$600K
Funding Federal Agency
National Center for Chronic Disease Prevention and Health Promotion
Awarding Federal Agency
Office of Financial Resources
Federal Grant Program
93.945
Assistance Type
Cooperative Agreement
Place of Performance
North Carolina, USA
Similar Awards
The University of North Carolina at Chapel Hill (UNC-CH) was awarded a $3,000,000 Cooperative Agreement under the Centers for Disease Control and Prevention's (CDC) Assistance Programs for Chronic Disease Prevention and Control (CFDA 93.945) on September 30, 2024. This 5-year award will fund research, intervention, and awareness initiatives focused on chronic disease prevention and management. Key products and services to be delivered include epidemiological research, implementation of...
The University of North Carolina at Chapel Hill has been awarded a $1,349,998 Cooperative Agreement from the Centers for Disease Control and Prevention (CDC) under the Centers for Research and Demonstration for Health Promotion and Disease Prevention program (CFDA 93.135). The award, effective from September 30, 2024 to September 29, 2029, will support the Cancer Prevention and Control Research Network (CPCRN) Coordinating and Collaborating Centers at UNC-Chapel Hill. Through this Cooperative...
This Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the Strengthening Public Health Systems and Services through National Partnerships to Improve and Protect the Nation's Health program (CFDA 93.421) provides $3,092,000.00 in funding to the University of North Carolina at Chapel Hill (UNC-CH) to serve as a Region 4 Center for Public Health Preparedness and Response. The 5-year award, running from September 30, 2024 to September 29, 2029, will enable...
This federal Project Grant award of $1,700,000 from the Centers for Disease Control and Prevention's Injury Prevention and Control Research and State and Community Based Programs (CFDA 93.136) supports the University of North Carolina at Chapel Hill's (UNC-CH) Injury Prevention Research Center. Awarded on August 1, 2024, with an ultimate completion date of July 31, 2029, this grant funds research, education, training, and direct services aimed at preventing various forms of injuries and...
This federal Cooperative Agreement award in the amount of $1,050,000.00 was granted by the Centers for Disease Control and Prevention (CDC) under the Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) program (CFDA 93.323). The award will fund the University of North Carolina at Chapel Hill (UNC-CH) to engage school communities in North Carolina to prevent exemptions to kindergarten vaccination mandates. The project period runs from September 30, 2024 to September 29, 2029. The...
The University of North Carolina at Chapel Hill (UNC-CH) received a $325,000 Project Grant from the Appalachian Regional Commission (ARC) under the Appalachian Research, Technical Assistance, and Demonstration Projects program (CFDA 23.011). The award, with a performance period from January 1, 2024 to March 31, 2025, will fund research and evaluation activities to expand knowledge of the Appalachian region and support ARC's strategic objectives. As a major public research university with...
The U.S. Centers for Disease Control and Prevention (CDC) awarded a $2,998,086 Cooperative Agreement under the Assistance Programs for Chronic Disease Prevention and Control (CFDA 93.945) to the Regents of the University of Minnesota, doing business as the Office of Sponsored Projects Administration. This 5-year award, with a project period from September 30, 2024 to September 29, 2029, will support the University of Minnesota Prevention Research Center's research, intervention, and awareness...
The U.S. Centers for Disease Control and Prevention (CDC) awarded a $900,000 Cooperative Agreement under the Assistance Programs for Chronic Disease Prevention and Control (CFDA 93.945) to the University of Massachusetts Medical School (UMass Medical) effective September 30, 2024 through September 29, 2029. The award supports the Physical Activity Policy Research and Evaluation Network, a research initiative focused on chronic disease prevention and control through policy interventions and...
The University of South Carolina was awarded a $499,528 Cooperative Agreement from the Centers for Disease Control and Prevention's Assistance Programs for Chronic Disease Prevention and Control (CFDA 93.945) to examine the dose-response relationship between physical activity and arthritis-attributable outcomes. The 5-year project, commencing on September 30, 2024 and running through September 29, 2029, will leverage the university's expertise in scientific research and population health to...
The University of North Carolina at Chapel Hill (UNC-CH) was awarded a $233,249 Cooperative Agreement under the Trans-NIH Research Support program (CFDA 93.310) by the National Institutes of Health (NIH) Office of the Director. The award, effective September 20, 2024 through June 30, 2028, supports the development of two novel tools: 1) a virus purification pipeline that can achieve less than 1 genome copy per milliliter sensitivity using larger sample volumes, and 2) a single virion detection...